Neuroanatomy Practice Questions

Q: Ureter develops from:

Metanephric Diverticulum. The development of the urinary system involves two primary components: the **Ureteric Bud (Metanephric Diverticulum)** and the **Metanephric Blastema (Metanephric Mesoderm)**. The **Metanephric Diverticulum** is a dorsal outgrowth from the mesonephric duct. It gives rise to the **collecting system** of the kidney, which includes the ureter, renal pelvis, major and minor calyces, and the collecting tubules [2]. Therefore, Option A is correct. **Analysis of Incorrect Options:** * **B. Metanephric Mesoderm (Blastema):** This forms the **excretory system** (nephrons), including the Bowman’s capsule, proximal convoluted tubule, Loop of Henle, and distal convoluted tubule. * **C. Metanephric Vesicles:** These are small structures derived from the metanephric mesoderm that eventually elongate to form the nephrons. * **D. Pronephric Vesicles:** The pronephros is a vestigial structure in humans that disappears early in embryonic life (around the 4th week) and does not contribute to the permanent kidney or ureter. **High-Yield Clinical Pearls for NEET-PG:** * **Reciprocal Induction:** The permanent kidney develops only if the ureteric bud and metanephric blastema interact. Failure of the ureteric bud to develop results in **Renal Agenesis**. * **Bifid Ureter:** Occurs due to early division of the ureteric bud [2]. * **Ectopic Ureter:** Results when the ureteric bud fails to incorporate correctly into the trigone of the bladder. * **Trigone of Bladder:** While the bladder is mostly endodermal (urogenital sinus), the trigone is derived from the absorbed mesonephric ducts (mesodermal) [1].

Q: At what age does a child typically reach a height of 100 cm?

4-5 years. The growth and development of a child follow predictable patterns, which are high-yield topics for NEET-PG. The correct answer is **4-5 years** because, on average, a child reaches the **100 cm (1 meter) mark at the age of 4 years.** [1] **Underlying Medical Concept:** At birth, the average length of a full-term neonate is approximately **50 cm**. Growth velocity is most rapid in the first year (increasing by ~25 cm). By age 2, the child is roughly **85-90 cm**. By age 4, the birth length typically **doubles**, reaching 100 cm. [1] This milestone is a standard benchmark used in pediatrics to assess constitutional growth. **Analysis of Options:** * **A & B (2-5 years / 3-5 years):** These ranges are too broad. While a child is within these ranges when they hit 100 cm, the specific milestone is most accurately associated with the 4th birthday. At 2 years, a child is significantly shorter (avg. 87 cm). * **C (4-5 years):** **Correct.** This captures the specific window where the average child crosses the 100 cm threshold. * **D (5-6 years):** By age 5, the average height is approximately 108-110 cm. Waiting until age 6 to reach 100 cm would indicate a potential growth delay (stunting). **High-Yield Clinical Pearls for NEET-PG:** * **Birth Length:** 50 cm. * **Double Birth Length:** 4 years (100 cm). * **Triple Birth Length:** 13 years (150 cm). * **Formula for Height (2-12 years):** (Age in years × 6) + 77 cm. * **Growth Velocity:** Height increases by 25 cm in the 1st year, 12 cm in the 2nd year, and roughly 6-7 cm/year thereafter until puberty.

Q: MCH class 3 genes encode which of the following?

Tumor necrosis factor. **Explanation:** The Major Histocompatibility Complex (MHC), located on the short arm of **chromosome 6**, is divided into three classes. While Class I and II are primarily involved in antigen presentation, **MHC Class III genes** encode a diverse group of proteins involved in the immune response, inflammation, and the complement system [1]. **Why Tumor Necrosis Factor (TNF) is correct:** The MHC Class III region is the most gene-dense region of the human genome. It contains genes for **Tumor Necrosis Factor (TNF-α and TNF-β/Lymphotoxin)** [1]. These are critical pro-inflammatory cytokines that mediate systemic inflammation and the acute phase response. **Analysis of Incorrect Options:** * **A. Complement components C3:** MHC Class III encodes complement components **C2, C4 (C4A and C4B), and Factor B** [1]. It does *not* encode C3, which is encoded on chromosome 19. * **C. IL2:** Interleukin-2 is a cytokine primarily produced by T-lymphocytes and is encoded on chromosome 4, not within the MHC complex [2]. * **D. Beta 2 microglobulin:** This is an essential component of the **MHC Class I** molecule, but it is encoded by a gene on **chromosome 15**, outside the MHC locus. **High-Yield NEET-PG Pearls:** 1. **MHC Class I:** Encoded by HLA-A, B, and C; presents endogenous antigens to CD8+ T-cells [1]. 2. **MHC Class II:** Encoded by HLA-DP, DQ, and DR; presents exogenous antigens to CD4+ T-cells. 3. **MHC Class III Products:** Remember the mnemonic **"C-H-T"**: **C**omplement (C2, C4), **H**eat shock proteins (HSP70), and **T**umor Necrosis Factor (TNF) [1]. 4. **Clinical Link:** MHC Class III genes are unique because, unlike Class I and II, they do not have a direct role in antigen presentation [1].

Q: The above condition is positive in which of the following stages of syphilis?

Secondary syphilis. ***Secondary syphilis*** - **VDRL/RPR tests** are most reliably positive in secondary syphilis with **99-100% positivity**, as this stage has the highest **bacterial load** and immune response. - Secondary syphilis presents with **systemic manifestations** like rash, lymphadenopathy, and condylomata lata, indicating widespread **spirochete dissemination**. *Primary syphilis* - **VDRL/RPR positivity** is only **70-80%** in primary syphilis, as the immune response is still developing during this early stage. - Many patients with **primary chancres** may still have **negative non-treponemal tests**, requiring treponemal-specific tests for diagnosis. *Chancroid* - Caused by **Haemophilus ducreyi**, not **Treponema pallidum**, so it cannot cause **true positive** VDRL/RPR results. - May occasionally cause **biological false positives** in non-treponemal tests, but this is uncommon and not diagnostically relevant. *Lymphogranuloma venereum (LGV)* - Caused by **Chlamydia trachomatis** serovars L1-L3, not **Treponema pallidum**, so cannot cause true positive results. - Like chancroid, may rarely cause **biological false positives** but is not associated with true syphilis serology positivity.

Q: Which is the only cranial nerve that does not have a ventral attachment at the base of the brain?

Trochlear. The **Trochlear nerve (CN IV)** is unique among all cranial nerves due to its specific embryological and anatomical origin. It is the **only cranial nerve** that emerges from the **dorsal (posterior) aspect** of the brainstem. ### Why Trochlear Nerve is Correct: The Trochlear nerve nuclei are located in the midbrain at the level of the inferior colliculus. The fibers decussate (cross over) within the superior medullary velum before emerging from the dorsal surface of the midbrain, just below the inferior colliculi. It then winds around the cerebral peduncles to reach the ventral surface and enter the cavernous sinus. ### Why Other Options are Incorrect: * **Optic Nerve (CN II):** This is a purely sensory nerve that attaches to the ventral surface of the brain at the optic chiasm and diencephalon [1]. * **Oculomotor Nerve (CN III):** It emerges from the ventral aspect of the midbrain, specifically from the interpeduncular fossa [1]. * **Trigeminal Nerve (CN V):** It emerges from the ventrolateral aspect of the pons at the junction of the pons and the middle cerebellar peduncle. ### NEET-PG High-Yield Facts: 1. **Longest Intracranial Course:** CN IV has the longest intracranial (subarachnoid) course, making it highly susceptible to trauma. 2. **Smallest Cranial Nerve:** It is the thinnest/slenderest of all cranial nerves. 3. **Complete Decussation:** It is the only cranial nerve where all fibers decussate before emerging. 4. **Clinical Correlation:** Paralysis of CN IV leads to **diplopia (double vision)** when looking downwards and inwards (e.g., walking down stairs or reading) [2]. Patients often present with a compensatory **head tilt** to the opposite side.

Q: Two drugs having opposite actions on different receptors demonstrate which type of antagonism?

Psychological antagonism. **Explanation:** The question describes **Physiological (Functional) Antagonism**, often referred to in some contexts as "psychological" antagonism (though "physiological" is the standard pharmacological term). This occurs when two agonists act on **different receptors** and produce **opposite effects** on the same physiological system [1]. **Why Option A is Correct:** In physiological antagonism, the drugs do not compete for the same binding site. Instead, they activate distinct pathways that counteract each other. A classic example is **Histamine** (acting on $H_1$ receptors to cause bronchoconstriction) and **Adrenaline** (acting on $\beta_2$ receptors to cause bronchodilation). **Why the other options are incorrect:** * **B. Physical Antagonism:** This is based on the physical properties of the drugs (e.g., Charcoal adsorbing alkaloids in the gut). No receptors are involved. * **C. Competitive Antagonism:** The antagonist binds to the **same receptor** as the agonist. This can be overcome by increasing the concentration of the agonist (surmountable). * **D. Non-competitive Antagonism:** The antagonist binds to an **allosteric site** or irreversibly to the active site of the same receptor, preventing the agonist from triggering a response regardless of concentration. **High-Yield Clinical Pearls for NEET-PG:** * **Chemical Antagonism:** Occurs when two substances react chemically to form an inactive product (e.g., Chelating agents like EDTA for lead poisoning or Protamine sulfate for Heparin). * **Adrenaline in Anaphylaxis:** This is the most high-yield example of **Physiological Antagonism**. Adrenaline counteracts the massive histamine release by acting on different receptors ($\alpha$ and $\beta$) to raise blood pressure and dilate airways. * **Key Distinction:** If the question mentions "same receptor," think Competitive/Non-competitive. If it mentions "different receptors/opposite effects," think Physiological.

Q: Which of the following are regulator proteins?

Both Troponin and Tropomyosin. In skeletal and cardiac muscle contraction, proteins are categorized based on their function into contractile, regulatory, and structural proteins. [2] **Understanding the Concept:** The correct answer is **Both Troponin and Tropomyosin** because these two proteins work together to regulate the interaction between actin and myosin. [2] * **Tropomyosin:** A long, rod-like protein that winds around the actin filament. In a resting state, it physically covers the myosin-binding sites on actin, preventing contraction. * **Troponin:** A complex of three subunits (TnT, TnI, and TnC). When calcium levels rise, calcium binds to **Troponin C**, causing a conformational change that pulls tropomyosin away from the binding sites, allowing the "power stroke" to occur. **Analysis of Options:** * **Option A (Troponin):** While correct, it is incomplete on its own as tropomyosin also serves a regulatory role. * **Option B (Tropomyosin):** Similarly, it is a regulatory protein but does not function independently of the troponin complex. * **Option D (None):** Incorrect, as both proteins are the primary regulators of the sliding filament mechanism. [2] **High-Yield NEET-PG Pearls:** 1. **Contractile Proteins:** Actin (thin filament) and Myosin (thick filament). [2] 2. **Structural Proteins:** Titin (largest protein, provides elasticity), Nebulin, and Dystrophin (defective in Duchenne Muscular Dystrophy). [1] 3. **Clinical Marker:** **Troponin I and T** are highly specific cardiac biomarkers used in the diagnosis of Myocardial Infarction (MI). 4. **Calcium Source:** In skeletal muscle, calcium is released from the Sarcoplasmic Reticulum; in cardiac muscle, it involves Calcium-Induced Calcium Release (CICR). [1]

Q: Which of the following cranial nerves has no somatic motor nucleus?

Facial. The key to answering this question lies in understanding the functional components of cranial nerve nuclei. In neuroanatomy, **Somatic Motor (General Somatic Efferent - GSE)** nuclei supply muscles derived from **somites** (e.g., extraocular and tongue muscles). In contrast, muscles derived from **pharyngeal (branchial) arches** are supplied by **Special Visceral Efferent (SVE)** nuclei. 1. **Why Facial Nerve (CN VII) is correct:** The motor nucleus of the facial nerve is classified as **SVE (Special Visceral Efferent)** because it supplies the muscles of facial expression, which are derived from the **second pharyngeal arch**, not somites. Therefore, CN VII has no somatic motor (GSE) component. 2. **Why the other options are incorrect:** * **Oculomotor (CN III), Trochlear (CN IV), and Abducens (CN VI)** all possess **GSE nuclei**. These nerves supply the extraocular muscles (Superior, Inferior, Medial Recti, Inferior Oblique for CN III; Superior Oblique for CN IV; Lateral Rectus for CN VI), all of which are derived from pre-otic somites. **High-Yield NEET-PG Pearls:** * **GSE (Somatic Motor) Nerves:** III, IV, VI, and XII (The "pure" motor nerves to somite-derived muscles). * **SVE (Branchiomotor) Nerves:** V (1st arch), VII (2nd arch), IX (3rd arch), X & XI (4th/6th arches). * **Nucleus Ambiguus:** A critical SVE nucleus for CN IX and X, supplying muscles of the larynx and pharynx. * **Rule of 4s:** CN III and IV are in the midbrain; V, VI, VII, and VIII are in the pons; IX, X, XI, and XII are in the medulla.

Q: Which drug blocks both H1 and 5-HT2 receptors?

Cyproheptadine. **Explanation:** **Cyproheptadine** is a first-generation antihistamine with a unique pharmacological profile. It acts as a potent antagonist at both **H1 (histamine)** receptors and **5-HT2 (serotonin)** receptors. This dual blockade is the underlying medical concept that makes it effective for specific clinical conditions beyond simple allergies. **Analysis of Options:** * **Cyproheptadine (Correct):** Its anti-serotonergic action (5-HT2 blockade) makes it the drug of choice for treating **Serotonin Syndrome**. Its H1-blocking property contributes to its sedative effects and its use in treating allergic rhinitis and urticaria. * **Phenoxybenzamine:** This is a non-selective, irreversible **alpha-adrenergic blocker** used primarily in the management of pheochromocytoma. It does not have significant H1 or 5-HT2 activity. * **Ritanserin:** This is a selective **5-HT2 receptor antagonist**. While it shares the serotonin-blocking property of cyproheptadine, it lacks significant H1 receptor antagonism. * **Ondansetron:** This is a selective **5-HT3 receptor antagonist** used primarily as an anti-emetic. It does not block H1 or 5-HT2 receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Serotonin Syndrome:** Cyproheptadine is the specific antidote/management drug. * **Appetite Stimulation:** Due to its 5-HT2 antagonism in the hypothalamus, cyproheptadine is used off-label as an appetite stimulant in children and patients with failure to thrive. * **Cushing’s Disease:** It was historically used to reduce ACTH secretion (via serotonin inhibition), though it is rarely used for this now. * **Dumping Syndrome:** It can be used to manage post-gastrectomy dumping syndrome due to its anti-serotonergic effects.

Q: The common carotid artery is formed by which embryonic aortic arch?

The 3rd aortic arch. The development of the arterial system involves the transformation of six pairs of embryonic aortic arches. The **3rd aortic arch** is responsible for the formation of the **Common Carotid Artery** and the proximal part of the **Internal Carotid Artery**. The distal part of the internal carotid is derived from the cranial portion of the dorsal aorta. **Analysis of Options:** * **Option A (2nd Arch):** This arch largely disappears, but its remnants form the **Stapedial** and **Hyoid** arteries. * **Option C (4th Arch):** This arch has asymmetrical derivatives. The **left** 4th arch forms part of the **Arch of Aorta** (between the left common carotid and left subclavian), while the **right** 4th arch forms the proximal segment of the **Right Subclavian Artery** [2]. * **Option D (6th Arch):** Also known as the Pulmonary arch. The **right** side forms the proximal part of the right pulmonary artery, while the **left** side forms the left pulmonary artery and the **Ductus Arteriosus** (which becomes the Ligamentum arteriosum after birth) [1]. **High-Yield NEET-PG Pearls:** * **1st Arch:** Forms the **Maxillary artery** (Mnemonic: 1st is Max). * **5th Arch:** Rudimentary and usually regresses completely. * **Recurrent Laryngeal Nerve:** Its relationship with the arches explains its course. The right nerve hooks around the 4th arch derivative (subclavian), while the left hooks around the 6th arch derivative (ligamentum arteriosum) [1]. * **Carotid Body/Sinus:** These are also associated with the 3rd arch, explaining their innervation by the Glossopharyngeal nerve (nerve of the 3rd arch).

Question 1

Ureter develops from:

Accepted Answer

Metanephric Diverticulum

Answer

Metanephric Mesoderm

Answer

Metanephric Vesicles

Answer

Pronephric Vesicles

Question 2

At what age does a child typically reach a height of 100 cm?

Accepted Answer

4-5 years

Answer

2-5 years

Answer

3-5 years

Answer

5-6 years

Question 3

MCH class 3 genes encode which of the following?

Accepted Answer

Tumor necrosis factor

Answer

Complement components C3

Answer

IL2

Answer

Beta 2 microglobulin

Question 4

The above condition is positive in which of the following stages of syphilis?

Accepted Answer

Secondary syphilis

Answer

Primary syphilis

Answer

Chancroid

Answer

Lymphogranuloma venereum (LGV)

Question 5

Which is the only cranial nerve that does not have a ventral attachment at the base of the brain?

Accepted Answer

Trochlear

Answer

Trigeminal

Answer

Optic

Answer

Oculomotor

Question 6

Two drugs having opposite actions on different receptors demonstrate which type of antagonism?

Accepted Answer

Psychological antagonism

Answer

Physical antagonism

Answer

Competitive antagonism

Answer

Non-competitive antagonism

Question 7

Which of the following are regulator proteins?

Accepted Answer

Both Troponin and Tropomyosin

Answer

Troponin

Answer

Tropomyosin

Answer

None of the above

Question 8

Which of the following cranial nerves has no somatic motor nucleus?

Accepted Answer

Facial

Answer

Oculomotor

Answer

Trochlear

Answer

Abducens

Question 9

Which drug blocks both H1 and 5-HT2 receptors?

Accepted Answer

Cyproheptadine

Answer

Phenoxybenzamine

Answer

Ritanserin

Answer

Ondansetron

Question 10

The common carotid artery is formed by which embryonic aortic arch?

Accepted Answer

The 3rd aortic arch

Answer

The 2nd aortic arch

Answer

The 4th aortic arch

Answer

The 6th aortic arch

Neuroanatomy — MCQs

Neuroanatomy — MCQs

On this page

Practice by Chapter

Want unlimited practice?